Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticas

Introduction: For the diagnosis of liver diseases, clinical criteria, biochemical, immunological and histological parameters are included. The autoimmune panel is an immunoblot that contemplates the detection of antibodies against 9 different hepatic antigens, which could guide the diagnosis of these pathologies. Objective: To describe the usefulness of the autoimmune panel in the diagnosis of liver diseases. Methods: Observational, descriptive study. All autoimmune panels performed between January 2020 and August 2021 (n = 279) were reviewed, and the ones with positive result selected (n = 101). Clinical records were reviewed, including: clinical, biochemical, immunological and histological characteristics. Diagnosis was determined by clinical suspicion (clinical, biochemical and immunological parameters), only through autoimmune panel, and according to liver biopsy in available cases. Results: 45 patients with complete clinical history were included in the analysis; 82% women, median age 58 years (16-79). Clinical suspicions included autoimmune hepatitis (AIH) in 12 patients (27%), primary biliary cholangitis (PBC) in 10 patients (22%), overlap syndrome (AIH/PBC) in 17 (38%), and others in 6 (13%). The diagnosis of PBC was confirmed by autoimmune panel in 9/10 and 11/17 patients with clinical suspicion of PBC and HAI/PBC, respectively. Of the 27 patients with initial clinical suspicion of PBC, 14 had negative AMA and AMA-M2 (6 had Sp100 and 5 gp210 as the only markers and 3 had positive Sp100 and PML). In 10/14 patients, the diagnosis was confirmed by panel and/or compatible liver biopsy. Conclusion: The autoimmune panel turns out to be a useful diagnostic tool for liver diseases, especially PBC in isolation or in overlap syndrome.

Saved in:
Bibliographic Details
Main Authors: Chelech,Fodda, Marcel Bonilla,José, Poniachik,Jaime, Urzúa,Álvaro, Simian,Daniela, Hurtado,Carmen
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2023
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872023000400461
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872023000400461
record_format ojs
spelling oai:scielo:S0034-988720230004004612024-04-14Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticasChelech,FoddaMarcel Bonilla,JoséPoniachik,JaimeUrzúa,ÁlvaroSimian,DanielaHurtado,Carmen Autoimmune Disease Liver Disease Autoantibodies Introduction: For the diagnosis of liver diseases, clinical criteria, biochemical, immunological and histological parameters are included. The autoimmune panel is an immunoblot that contemplates the detection of antibodies against 9 different hepatic antigens, which could guide the diagnosis of these pathologies. Objective: To describe the usefulness of the autoimmune panel in the diagnosis of liver diseases. Methods: Observational, descriptive study. All autoimmune panels performed between January 2020 and August 2021 (n = 279) were reviewed, and the ones with positive result selected (n = 101). Clinical records were reviewed, including: clinical, biochemical, immunological and histological characteristics. Diagnosis was determined by clinical suspicion (clinical, biochemical and immunological parameters), only through autoimmune panel, and according to liver biopsy in available cases. Results: 45 patients with complete clinical history were included in the analysis; 82% women, median age 58 years (16-79). Clinical suspicions included autoimmune hepatitis (AIH) in 12 patients (27%), primary biliary cholangitis (PBC) in 10 patients (22%), overlap syndrome (AIH/PBC) in 17 (38%), and others in 6 (13%). The diagnosis of PBC was confirmed by autoimmune panel in 9/10 and 11/17 patients with clinical suspicion of PBC and HAI/PBC, respectively. Of the 27 patients with initial clinical suspicion of PBC, 14 had negative AMA and AMA-M2 (6 had Sp100 and 5 gp210 as the only markers and 3 had positive Sp100 and PML). In 10/14 patients, the diagnosis was confirmed by panel and/or compatible liver biopsy. Conclusion: The autoimmune panel turns out to be a useful diagnostic tool for liver diseases, especially PBC in isolation or in overlap syndrome.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.151 n.4 20232023-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872023000400461es10.4067/s0034-98872023000400461
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Chelech,Fodda
Marcel Bonilla,José
Poniachik,Jaime
Urzúa,Álvaro
Simian,Daniela
Hurtado,Carmen
spellingShingle Chelech,Fodda
Marcel Bonilla,José
Poniachik,Jaime
Urzúa,Álvaro
Simian,Daniela
Hurtado,Carmen
Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticas
author_facet Chelech,Fodda
Marcel Bonilla,José
Poniachik,Jaime
Urzúa,Álvaro
Simian,Daniela
Hurtado,Carmen
author_sort Chelech,Fodda
title Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticas
title_short Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticas
title_full Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticas
title_fullStr Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticas
title_full_unstemmed Evaluación del panel de enfermedades hepáticas autoinmunes (INMUNOBLOT) en el diagnóstico de enfermedades hepáticas
title_sort evaluación del panel de enfermedades hepáticas autoinmunes (inmunoblot) en el diagnóstico de enfermedades hepáticas
description Introduction: For the diagnosis of liver diseases, clinical criteria, biochemical, immunological and histological parameters are included. The autoimmune panel is an immunoblot that contemplates the detection of antibodies against 9 different hepatic antigens, which could guide the diagnosis of these pathologies. Objective: To describe the usefulness of the autoimmune panel in the diagnosis of liver diseases. Methods: Observational, descriptive study. All autoimmune panels performed between January 2020 and August 2021 (n = 279) were reviewed, and the ones with positive result selected (n = 101). Clinical records were reviewed, including: clinical, biochemical, immunological and histological characteristics. Diagnosis was determined by clinical suspicion (clinical, biochemical and immunological parameters), only through autoimmune panel, and according to liver biopsy in available cases. Results: 45 patients with complete clinical history were included in the analysis; 82% women, median age 58 years (16-79). Clinical suspicions included autoimmune hepatitis (AIH) in 12 patients (27%), primary biliary cholangitis (PBC) in 10 patients (22%), overlap syndrome (AIH/PBC) in 17 (38%), and others in 6 (13%). The diagnosis of PBC was confirmed by autoimmune panel in 9/10 and 11/17 patients with clinical suspicion of PBC and HAI/PBC, respectively. Of the 27 patients with initial clinical suspicion of PBC, 14 had negative AMA and AMA-M2 (6 had Sp100 and 5 gp210 as the only markers and 3 had positive Sp100 and PML). In 10/14 patients, the diagnosis was confirmed by panel and/or compatible liver biopsy. Conclusion: The autoimmune panel turns out to be a useful diagnostic tool for liver diseases, especially PBC in isolation or in overlap syndrome.
publisher Sociedad Médica de Santiago
publishDate 2023
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872023000400461
work_keys_str_mv AT chelechfodda evaluaciondelpaneldeenfermedadeshepaticasautoinmunesinmunobloteneldiagnosticodeenfermedadeshepaticas
AT marcelbonillajose evaluaciondelpaneldeenfermedadeshepaticasautoinmunesinmunobloteneldiagnosticodeenfermedadeshepaticas
AT poniachikjaime evaluaciondelpaneldeenfermedadeshepaticasautoinmunesinmunobloteneldiagnosticodeenfermedadeshepaticas
AT urzuaalvaro evaluaciondelpaneldeenfermedadeshepaticasautoinmunesinmunobloteneldiagnosticodeenfermedadeshepaticas
AT simiandaniela evaluaciondelpaneldeenfermedadeshepaticasautoinmunesinmunobloteneldiagnosticodeenfermedadeshepaticas
AT hurtadocarmen evaluaciondelpaneldeenfermedadeshepaticasautoinmunesinmunobloteneldiagnosticodeenfermedadeshepaticas
_version_ 1798168115760070656